|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0013216,
umls-concept:C0015730,
umls-concept:C0016360,
umls-concept:C0030231,
umls-concept:C0087111,
umls-concept:C0205195,
umls-concept:C0281361,
umls-concept:C0392752,
umls-concept:C1274040,
umls-concept:C1519810,
umls-concept:C1521996,
umls-concept:C1522449,
umls-concept:C1522673
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-4-4
|
|
pubmed:abstractText |
To evaluate a cisplatin-containing chemoradiotherapy (CRT) regimen followed by chemotherapy for unresectable (locally advanced group, n = 32) and resected (adjuvant group, n = 10) pancreatic adenocarcinoma. The quality of palliation and percentage of secondary resections were also studied for unresectable disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
pubmed-author:AndréTT,
pubmed-author:BalossoJJ,
pubmed-author:BellaïcheAA,
pubmed-author:ColonnaMM,
pubmed-author:De GramontAA,
pubmed-author:HannounLL,
pubmed-author:HourySS,
pubmed-author:HuguierMM,
pubmed-author:IzraelVV,
pubmed-author:LotzJ PJP,
pubmed-author:LouvetCC,
pubmed-author:ParsBB,
pubmed-author:TouboulEE
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
903-11
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10705012-Adenocarcinoma,
pubmed-meshheading:10705012-Adult,
pubmed-meshheading:10705012-Aged,
pubmed-meshheading:10705012-Analysis of Variance,
pubmed-meshheading:10705012-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10705012-Cisplatin,
pubmed-meshheading:10705012-Combined Modality Therapy,
pubmed-meshheading:10705012-Feasibility Studies,
pubmed-meshheading:10705012-Female,
pubmed-meshheading:10705012-Fluorouracil,
pubmed-meshheading:10705012-Humans,
pubmed-meshheading:10705012-Male,
pubmed-meshheading:10705012-Matched-Pair Analysis,
pubmed-meshheading:10705012-Middle Aged,
pubmed-meshheading:10705012-Neoplasm Staging,
pubmed-meshheading:10705012-Palliative Care,
pubmed-meshheading:10705012-Pancreatic Neoplasms,
pubmed-meshheading:10705012-Quality of Life,
pubmed-meshheading:10705012-Survival Analysis
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.
|
|
pubmed:affiliation |
Department of Medical Oncology, University Hospital, Grenoble, France. thierry.andre@tnn.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
